题名 | miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway |
作者 | |
发表日期 | 2023 |
发表期刊 | Cancer Biology and Therapy; 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | APOC1 Glioblastoma miRNA-660-3p TGFβ2 signaling pathway TGF beta 2 signaling pathway |
其他关键词 | APOLIPOPROTEIN C1 APOC1 ; PROGNOSTIC BIOMARKER ; PANCREATIC-CANCER ; LUNG-CANCER ; PROGRESSION ; BETA ; PROMOTES ; GROWTH ; CELLS ; PROLIFERATION |
摘要 | Glioblastoma as the most common and aggressive central nervous system tumor in adults. Its prognosis and therapeutic outcome are poor due to the limited understanding of its molecular mechanism. Apolipoprotein C-1 (APOC1) as a member of the apolipoprotein family that acts as a tumor promoter in various cancers. MicroRNA (miRNA) can silence gene expression and suppress tumor progression. However, the role of APOC1 and its upstream miRNA has not been explored in glioblastoma. Two glioblastoma cell lines (U87 and U251) were used to explore the role of APOC1 and its upstream miRNA-660-3p in glioblastoma tumorigenesis in vitro. Cells with APOC1/miRNA-660-3p overexpression or knockdown were assessed for their proliferation, migration, and invasion in vitro, and tumorigenesis in vivo. Gene and protein expression was assessed by qRT-PCR and western blot, respectively. Cell proliferation was assessed by the MTT assay and the EdU and Ki67 staining. Cell migration and invasion were assessed by the transwell assay. Tumorigenesis in vivo was assessed in U87 cells with a xenograft mouse model. APOC1 was overexpressed in glioblastoma compared with normal peritumoral tissue and was inversely related to patient prognosis. APOC1 overexpression promotes cell proliferation, migration, and invasion in vitro. APOC1 inhibition reduced tumor growth in vivo. miRNA-660-3p inhibits tumorigenesis by directly targeting APOC1. Mechanistically, APOC1 drives the malignancy of glioblastoma by activating the TGFβ2 signaling pathway. miRNA-660-3p suppresses tumorigenesis by targeting APOC1. Therefore, miRNA-660-3p/APOC1 axis can serve as potential intervention targets in managing glioblastoma progression. |
资助项目 | Wenzhou Municipal Sci-Tech Bureau[ZY2021007];Science and Technology Department of Zhejiang Province[GF22H162840]; |
出版者 | TAYLOR & FRANCIS INC |
ISSN | 1538-4047 |
EISSN | 1555-8576 |
卷号 | 24期号:1 |
DOI | 10.1080/15384047.2023.2281459 |
页数 | 11 |
WOS类目 | Oncology |
WOS研究方向 | Oncology |
WOS记录号 | WOS:001107671600001 |
收录类别 | SCOPUS ; SCIE ; PUBMED |
URL | 查看原文 |
PubMed ID | 37981873 |
SCOPUSEID | 2-s2.0-85177447110 |
通讯作者地址 | [Dong, Qiaoxiang]Wenzhou Medical University,Zhejiang,Wenzhou,China |
Scopus学科分类 | Molecular Medicine;Oncology;Pharmacology;Cancer Research |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/184704 |
专题 | 附属第二医院 公共卫生学院 |
通讯作者 | Dong, Qiaoxiang |
作者单位 | 1.Department of Neurosurgery,The Second Affiliated Hospital and Yuying Children’s Hospital,Wenzhou Medical University,Wenzhou,China; 2.School of Public Health and Management,Wenzhou Medical University,Wenzhou,China |
第一作者单位 | 附属第二医院; 公共卫生学院 |
通讯作者单位 | 温州医科大学 |
第一作者的第一单位 | 附属第二医院 |
推荐引用方式 GB/T 7714 | Yang, Zelin,Yang, Liang,Sun, Zhenkai,et al. miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway[J]. Cancer Biology and Therapy;,2023,24(1). |
APA | Yang, Zelin., Yang, Liang., Sun, Zhenkai., Rong, Yuxi., Bai, Chenglian., ... & Jian, Lin. (2023). miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway. Cancer Biology and Therapy;, 24(1). |
MLA | Yang, Zelin,et al."miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway".Cancer Biology and Therapy; 24.1(2023). |
条目包含的文件 | 条目无相关文件。 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论